MYD.DE

Myriad Genetics, Inc. [MYD.DE] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

MYD.DE Stock Summary

In the News

MYD.DE Financial details

Company Rating
Neutral
Market Cap
2.15B
Income
-274.4M
Revenue
734.4M
Book val./share
8.36
Cash/share
1.06
Dividend
-
Dividend %
-
Employees
2.7K
Optionable
No
Shortable
Yes
Earnings
01 May 2024
P/E
-8.71
Forward P/E
-
PEG
-0.1
P/S
3.21
P/B
3.5
P/C
-
P/FCF
-17.05
Quick Ratio
0.96
Current Ratio
1.27
Debt / Equity
0.29
LT Debt / Equity
0.27
-
-
EPS (TTM)
-3.4
EPS next Y
-
EPS next Q
-
EPS this Y
297.14%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-4.43%
Revenue Q/Q
4.58%
EPS Q/Q
-47.92%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-24%
ROE
-35%
ROC
-0.29%
Gross Margin
69%
Oper. Margin
-37%
Profit Margin
-37%
Payout
-
Shs Outstand
80.63M
Shs Float
74.59M
-
-
-
-
Target Price
-
52W Range
15.51-30.8
52W High
-
52W Low
-
RSI
-
Rel Volume
0.13
Avg Volume
8
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
1.963
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-

MYD.DE Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2019-06-302020-06-302020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
11.588.597.468.898.44
Net income per share
0.06-2.69-2.99-0.35-1.39
Operating cash flow per share
1.140.82-0.360.23-1.32
Free cash flow per share
1.020.68-0.540-1.89
Cash per share
1.862.932.024.371.43
Book value per share
14.8112.3611.7912.4511.02
Tangible book value per share
-0.18-0.2-0.364.182.73
Share holders equity per share
14.8112.3611.7912.4511.02
Interest debt per share
3.934.113.011.271.84
Market cap
1.17B794.12M1.37B2.14B2.29B
Enterprise value
1.31B925.22M1.26B1.98B2.38B
P/E ratio
254.24-3.98-6.14-78.79-20.46
Price to sales ratio
1.371.242.473.13.38
POCF ratio
13.9713.08-51.06117.75-21.55
PFCF ratio
15.5715.73-34.2510.72K-15.11
P/B Ratio
1.070.861.562.212.59
PTB ratio
1.070.861.562.212.59
EV to sales
1.541.452.262.863.51
Enterprise value over EBITDA
15.21-21.22-10.18140.21-35.09
EV to operating cash flow
15.6515.24-46.71108.63-22.38
EV to free cash flow
17.4418.32-31.349.88K-15.69
Earnings yield
0-0.25-0.16-0.01-0.05
Free cash flow yield
0.060.06-0.030-0.07
Debt to equity
0.250.320.260.10.16
Debt to assets
0.180.210.160.070.12
Net debt to EBITDA
1.63-3.010.95-11.78-1.3
Current ratio
2.962.262.672.372
Interest coverage
0.63-21.450-7.38-38.66
Income quality
18.2-0.30.12-0.670.95
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.650.800.870.76
Research and developement to revenue
0.10.120.150.120.13
Intangibles to total assets
0.710.660.640.490.56
Capex to operating cash flow
-0.1-0.170.49-0.990.43
Capex to revenue
-0.01-0.02-0.02-0.03-0.07
Capex to depreciation
-0.12-0.14-0.18-0.29-0.86
Stock based compensation to revenue
0.040.040.040.050.06
Graham number
4.5727.3228.199.918.58
ROIC
0.01-0.16-0.21-0.02-0.08
Return on tangible assets
0.01-0.42-0.44-0.04-0.21
Graham Net
-2.96-2.7-4.10.81-1.39
Working capital
230.8M184.7M243.5M280.5M137.4M
Tangible asset value
-13M-14.7M-27M324.5M219.3M
Net current asset value
-125.2M-154.7M-148.4M131.9M-38.3M
Invested capital
0.250.320.260.10.16
Average receivables
120.35M104.8M80.25M90.4M96.45M
Average payables
29.65M27.5M21.1M25.05M29.2M
Average inventory
32.85M30.25M28.1M21.2M17.7M
Days sales outstanding
59.4440.5858.6548.2554.66
Days payables outstanding
60.4742.5641.9954.6852.04
Days of inventory on hand
57.0257.0755.5128.2636.32
Receivables turnover
6.148.996.227.566.68
Payables turnover
6.048.588.696.687.01
Inventory turnover
6.46.46.5812.9210.05
ROE
0-0.22-0.25-0.03-0.13
Capex per share
-0.12-0.14-0.18-0.23-0.56

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
1.952.212.252.282.35
Net income per share
-0.44-0.53-0.68-1.44-0.75
Operating cash flow per share
-0.02-0.1-0.41-0.01-0.27
Free cash flow per share
-0.24-0.28-0.71-0.25-0.48
Cash per share
2.41.430.981.511.06
Book value per share
11.411.0210.399.148.36
Tangible book value per share
3.852.732.221.110.49
Share holders equity per share
11.411.0210.399.148.36
Interest debt per share
1.721.812.022.542.48
Market cap
2.11B2.29B2.34B2.34B2.31B
Enterprise value
2.14B2.38B2.45B2.44B2.44B
P/E ratio
-15.04-13.54-10.71-5.04-9.44
Price to sales ratio
13.512.8912.9312.7612.06
POCF ratio
-1.17K-297.54-70.56-2.6K-104.75
PFCF ratio
-108.29-102.74-41.32-118.86-58.46
P/B Ratio
2.32.592.83.193.39
PTB ratio
2.32.592.83.193.39
EV to sales
13.6713.3813.5213.3112.72
Enterprise value over EBITDA
-70.57-76.01-74.94-23.88-52.94
EV to operating cash flow
-1.19K-308.99-73.81-2.71K-110.42
EV to free cash flow
-109.66-106.69-43.22-123.99-61.62
Earnings yield
-0.02-0.02-0.02-0.05-0.03
Free cash flow yield
-0.01-0.01-0.02-0.01-0.02
Debt to equity
0.150.160.190.280.29
Debt to assets
0.110.120.140.170.18
Net debt to EBITDA
-0.88-2.81-3.3-0.99-2.72
Current ratio
2.7321.831.331.27
Interest coverage
-56.25-51.11-104.4-227.4-60.1
Income quality
0.050.180.610.010.36
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00.820.841.190.89
Research and developement to revenue
0.130.130.120.120.13
Intangibles to total assets
0.50.560.560.540.56
Capex to operating cash flow
9.831.90.7120.890.79
Capex to revenue
-0.11-0.08-0.13-0.1-0.09
Capex to depreciation
-1.35-1.07-1.21-1.41-1.24
Stock based compensation to revenue
0.060.050.040.060.06
Graham number
10.5811.4212.6117.2411.88
ROIC
-0.03-0.03-0.05-0.1-0.06
Return on tangible assets
-0.06-0.08-0.11-0.21-0.12
Graham Net
-0.2-1.39-1.93-2.93-3.43
Working capital
223.2M137.4M118.3M73.2M56.1M
Tangible asset value
309.3M219.3M178.7M89.2M40.2M
Net current asset value
56.9M-38.3M-72.5M-157.7M-200.3M
Invested capital
0.150.160.190.280.29
Average receivables
106M101.9M110.35M115.4M113.45M
Average payables
25.65M29.2M32.65M38.15M36.85M
Average inventory
17.5M19.85M20.95M22.15M23.8M
Days sales outstanding
58.8151.4359.1654.7854.03
Days payables outstanding
52.8648.0955.4961.9752.97
Days of inventory on hand
3533.5633.1435.0339.22
Receivables turnover
1.531.751.521.641.67
Payables turnover
1.71.871.621.451.7
Inventory turnover
2.572.682.722.572.29
ROE
-0.04-0.05-0.07-0.16-0.09
Capex per share
-0.22-0.18-0.29-0.23-0.21

MYD.DE Frequently Asked Questions

What is Myriad Genetics, Inc. stock symbol ?

Myriad Genetics, Inc. is a US stock , located in Salt lake city of Ut and trading under the symbol MYD.DE

What is Myriad Genetics, Inc. stock quote today ?

Myriad Genetics, Inc. stock price is $- today.

Is Myriad Genetics, Inc. stock public?

Yes, Myriad Genetics, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Same Sector
Check Those
Similar Market Cap